OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
Yi Bai, Dapeng Chen, Chuanliang Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Yi Bai, Dapeng Chen, Chuanliang Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 24
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 24
IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma
Shreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu, et al.
Future Oncology (2024) Vol. 20, Iss. 28, pp. 2049-2057
Open Access | Times Cited: 8
Shreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu, et al.
Future Oncology (2024) Vol. 20, Iss. 28, pp. 2049-2057
Open Access | Times Cited: 8
Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma
Han Wang, Allan Tsung, Lopa Mishra, et al.
EBioMedicine (2024) Vol. 101, pp. 105031-105031
Open Access | Times Cited: 7
Han Wang, Allan Tsung, Lopa Mishra, et al.
EBioMedicine (2024) Vol. 101, pp. 105031-105031
Open Access | Times Cited: 7
The roles of enhancer, especially super-enhancer-driven genes in tumor metabolism and immunity
Shouwu Guo, Lu Zhang, Jiao Ren, et al.
International Journal of Biological Macromolecules (2025), pp. 142414-142414
Closed Access
Shouwu Guo, Lu Zhang, Jiao Ren, et al.
International Journal of Biological Macromolecules (2025), pp. 142414-142414
Closed Access
CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype
Binle Tian, Zhilong Wang, Mei Cao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Binle Tian, Zhilong Wang, Mei Cao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
Xiang Wang, Zijun Yuan, Zhengbo Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Xiang Wang, Zijun Yuan, Zhengbo Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
Chun Wu, Lianhui Duan, Hongmu Li, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 10
Chun Wu, Lianhui Duan, Hongmu Li, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 10
Spermine synthase engages in macrophages M2 polarization to sabotage antitumor immunity in hepatocellular carcinoma
Yining Sun, Peitao Zhou, Junying Qian, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 3
Yining Sun, Peitao Zhou, Junying Qian, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 3
CanCellVar: A database for single-cell variants map in human cancer
Changbo Yang, Yujie Liu, Chongwen Lv, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 7, pp. 1420-1430
Open Access | Times Cited: 2
Changbo Yang, Yujie Liu, Chongwen Lv, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 7, pp. 1420-1430
Open Access | Times Cited: 2
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Ying‐Hong Shi, Donglin Hao, Hui Qian, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Ying‐Hong Shi, Donglin Hao, Hui Qian, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
Giulia Milardi, Ana Lleò
Cancers (2023) Vol. 15, Iss. 7, pp. 2182-2182
Open Access | Times Cited: 6
Giulia Milardi, Ana Lleò
Cancers (2023) Vol. 15, Iss. 7, pp. 2182-2182
Open Access | Times Cited: 6
Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
Shu Zhao, Min‐Hang Zhou, Peng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 10
Shu Zhao, Min‐Hang Zhou, Peng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 10
Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
Aswathy R. Devan, Bhagyalakshmi Nair, Kanjoormana Aryan Manu, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2729-2729
Open Access | Times Cited: 4
Aswathy R. Devan, Bhagyalakshmi Nair, Kanjoormana Aryan Manu, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2729-2729
Open Access | Times Cited: 4
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma
Liping Wang, Shuang Li, Xinran Li, et al.
Neoplasia (2024) Vol. 50, pp. 100980-100980
Open Access | Times Cited: 1
Liping Wang, Shuang Li, Xinran Li, et al.
Neoplasia (2024) Vol. 50, pp. 100980-100980
Open Access | Times Cited: 1
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Yuxin Liang, Deyuan Zhong, Qinyan Yang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 373-383
Open Access | Times Cited: 1
Yuxin Liang, Deyuan Zhong, Qinyan Yang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 373-383
Open Access | Times Cited: 1
Current research insights into the role of CTLA ‐4 in hepatitis B virus (HBV ) infection
Qi Gu, Shengxia Yin, Xin Tong, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 9, pp. 557-564
Closed Access | Times Cited: 1
Qi Gu, Shengxia Yin, Xin Tong, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 9, pp. 557-564
Closed Access | Times Cited: 1
CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma
Jianghong Cheng, Junyang Li, Xinjie Jiang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Jianghong Cheng, Junyang Li, Xinjie Jiang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Enhancing cancer immunotherapy using cordycepin and Cordyceps militaris extract to sensitize cancer cells and modulate immune responses
Chutamas Thepmalee, Phanitaporn Jenkham, Boonyanuch Ramwarungkura, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Chutamas Thepmalee, Phanitaporn Jenkham, Boonyanuch Ramwarungkura, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
TIGIT Expression on Intratumoral Lymphocytes Correlates with Improved Prognosis in Oral Squamous Cell Carcinoma
Jonas Eichberger, Silvia Spoerl, Gerrit Spanier, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3236-3236
Open Access | Times Cited: 6
Jonas Eichberger, Silvia Spoerl, Gerrit Spanier, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3236-3236
Open Access | Times Cited: 6
Crosstalk of cuproptosis-related prognostic signature and competing endogenous RNAs regulation in hepatocellular carcinoma
Jun Zhu, Jingyan Wang, Hong Liu, et al.
Aging (2023) Vol. 15, Iss. 23, pp. 13901-13919
Open Access | Times Cited: 2
Jun Zhu, Jingyan Wang, Hong Liu, et al.
Aging (2023) Vol. 15, Iss. 23, pp. 13901-13919
Open Access | Times Cited: 2
Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy
Yun Liu, Yunhua Lin, Shijie Liao, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23601-e23601
Open Access | Times Cited: 2
Yun Liu, Yunhua Lin, Shijie Liao, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23601-e23601
Open Access | Times Cited: 2
Spermine Synthase Engages in Macrophages M2 polarization to Sabotage Antitumor Immunity in Hepatocellular Carcinoma
Yuan Fang, Yining Sun, Peitao Zhou, et al.
Research Square (Research Square) (2024)
Open Access
Yuan Fang, Yining Sun, Peitao Zhou, et al.
Research Square (Research Square) (2024)
Open Access
CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype
JianFei Wang, Binle Tian, Zhilong Wang, et al.
Research Square (Research Square) (2024)
Open Access
JianFei Wang, Binle Tian, Zhilong Wang, et al.
Research Square (Research Square) (2024)
Open Access
